Maternal-to-fetal transfer of thyrotropin-releasing hormone in vivo

被引:13
作者
Bajoria, R [1 ]
Peek, MJ [1 ]
Fisk, NM [1 ]
机构
[1] Queen Charlottes & Chelsea Hosp, Inst Obstet & Gynaecol, Royal Postgrad Med Sch, London W6 0XG, England
关键词
thyrotropin-releasing hormone; placental transfer; respiratory distress syndrome; preterm labor;
D O I
10.1016/S0002-9378(98)80011-2
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: Our purpose was to determine the transplacental transfer of thyrotropin-releasing hormone at the time of fetal blood sampling. STUDY DESIGN: Four hundred micrograms of thyrotropin-releasing hormone was given intravenously to 13 pregnant women between 24 and 35 weeks' gestation and maternal-to-fetal transfer of thyrotropin-releasing hormone was determined at fetal blood sampling 1 to 93 minutes later The fetal thyrotropic response to thyrotropin-releasing hormone was determined by measuring thyroid-stimulating hormone, thyroxine, and prolactin. For comparison, endogenous fetal and maternal levels of thyrotropin-releasing hormone, thyroid-stimulating hormone, thyroxine, and prolactin levels were determined in a further 20 patients undergoing fetal blood sampling between 19 and 35 weeks' gestation. The concentration of thyrotrophin-releasing hormone was measured by radioimmunoassay and thyroid-stimulating hormone, thyroxine, and prolactin by chemiluminescence assay. RESULTS: Thyrotropin-releasing hormone was undetectable in the maternal circulation, whereas endogenous levels were detectable in the fetus from 19 weeks' gestation (median 150; range 50 to 276 pmol/L) and did not correlate with gestational age. After thyrotropin-releasing hormone injection as an intravenous bolus, peak levels in the mother were attained at 3 minutes (50,000 pmol/L). Maximal transplacental transfer of thyrotropin-releasing hormone occurred within 5 minutes of maternal administration but accounted in fetal blood for only 0.01% of initial dose administered (median 250; 30 to 550 pmol/L. Thyrotropin-releasing hormone-stimulated fetal peak thyroid-stimulating hormone levels occurred within 13 minutes and were higher than maternal values (p < 0.001). There was no change in fetal prolactin level with thyrotropin-releasing hormone therapy. CONCLUSION: Although maternally administered thyrotropin-releasing hormone crosses the placenta sparingly, it still elicits a thyroid-stimulating hormone but not a prolactin response in the human fetus.
引用
收藏
页码:264 / 269
页数:6
相关论文
共 25 条
[1]   THYROTROPIN-RELEASING HORMONE-DEGRADING ACTIVITY OF NEONATAL HUMAN-PLASMA [J].
ARATANSPIRE, S ;
CZERNICHOW, P .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1980, 50 (01) :88-92
[2]   Transfer and metabolism of thyrotropin releasing hormone across the perfused human term placenta [J].
Bajoria, R ;
OtengNtim, E ;
Fisk, NM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (10) :3476-3482
[3]   Maternofetal transfer of thyrotrophin-releasing hormone: Effect of concentration and mode of administration [J].
Bajoria, R ;
Fisk, NM .
PEDIATRIC RESEARCH, 1997, 41 (05) :674-681
[4]   Pharmacokinetics and pharmacodynamics of TRH during pregnancy [J].
Bajoria, R ;
OtengNtim, E ;
Peek, MJ ;
Fisk, NM .
OBSTETRICS AND GYNECOLOGY, 1997, 90 (02) :176-182
[5]   TRANSFER OF HEPARIN ACROSS THE HUMAN PERFUSED PLACENTAL LOBULE [J].
BAJORIA, R ;
CONTRACTOR, SF .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1992, 44 (12) :952-959
[6]  
BAJORIA R, 1993, BRIT J HAEMATOL, V84, P59
[7]  
BEESTON JGT, 1991, NEW ENGL J MED, V324, P532
[8]  
BEESTON JGT, 1990, FETAL DIAGN THER, V5, P109
[9]  
CROWTHER CA, 1995, LANCET, V345, P877
[10]  
CROWTHER CA, 1995, COCHRANE DATABASE SY